Abstract: Intracranial tumor is one of the most common diseases in nervous system, which has great harm to the function of human nervous system. Surgical tumor resection is the primary treatment method for the disease. Ultrasonoscopy is helpful for lesion localization and boundary determination in intracranial tumor resection surgery resection rate improvement and reduction of postoperative tumor recurrence probability. However, the deficiency of routine ultrasound examination in image contrast leads to obvious limitation thereof in clinical application. The blood perfusion difference between pathological tissue and normal tissue can be utilized to increase the image contrast in ultrasound contrast, thereby providing more accurate and clearer ultrasonic image, assisting the performer to determine tumor boundary more accurately, understand the hemoperfusion status of tumor, judge residual tumor, and improving diagnosis accuracy and surgical resection rate.
scope. The tumor lesion was displayed under the two-dimensional gray order mode. The position, morphology, boundary, internal situation and edema of surrounding brain tissue were observed. The size of the lesion and the depth to the brain surface were measured. CDFI was started to display the adjacent relationship between the tumor and the important blood vessels around it.
Statistical analysis method
SPSS13.0 software was used for statistical processing. The measurement data was expressed with mean or plus standard deviation. The t test of independent samples was applied for mean comparison. The paired t test was used for pairing, and P < 0.05 was statistically significant.
Results
The surgery process was smooth and there were no serious complications after surgery. 73 cases of tumor total resection and 13 cases of secondary tumor total resection were reviewed within one week after surgery through CT or MRI. Postoperative pathological diagnosis showed that: 70 cases with glioma were diagnosed, 20 cases had astrocytoma (WHO Ⅰ -Ⅱ level), 19 cases had oligodendroglioma (WHO Ⅱ level), 17 cases had anaplastic astrocytoma s (WHO Ⅲ level), 14 cases had glioblastoma (WHO Ⅳ level); and 16 cases ahd brain metastatic tumor.
Tumor ultrasonic location
All lesions were well developed by intraoperative ultrasonography. The tumors were positioned, and the positioning accuracy was 100%. After contrast agent was injected, internal structure and boundary of the tumor were clearly displayed
Ultrasonogram characteristics of intracranial tumor
The normal brain tissue was hypoechoic under routine ultrasound examination. It was always enhanced after the contrast agent was injected. After all tumors were injected with contrast agent, they were enhanced at different degrees, and their enhancement time, intensity and distribution were different. Ultrasonogram accurately showed the location of tumor, the boundary of the tumor, tumor internal blood vessels, relations with adjacent blood vessels and tumor blood perfusion characteristics in real time. The time-intensity curve (TIC) was drawn through Qontrast ® software, contrast enhancement policy index was obtained, and the control pathology results were shown in Table 1 in details. the tumor were clearly displayed after contrast, which were manifested as irregular enhancement. The reinforcement gradually faded later.
Residual tumor judgement
The pathological examination results were regarded as gold standards, the comparison between routine ultrasound examination and results of pathological examination to judge neoplasm residual was shown in Table 2 , judgment sensitivity was 41.7%, specificity was 95.2%, false positive rate was 4.8%, false negative rate was 58.3%; the comparison between ultrasound contrast and results of pathological examination to judge neoplasm residual was shown in Table 3 , judgment sensitivity was 83.3%, specificity was 100%, false positive rate was 0, and false negative rate was 16.7%. LGG: low-grade gliomas; HGG: high-grade gliomas; T1: enhancement starting time; T2: time to peak; T3: enhancement extinction time 
Discussion
The primary treatment method for intracranial tumor is surgical resection. The basic principle of surgical resection is shown as follows: the tumor is removed to the maximum extent under the premise of protecting the nerve function [1] . Different technologies were applied in neurosurgery to reduce surgical injury in order to optimize the effect of surgical resection, such as navigation system, intraoperative MRI, intraoperative ultrasonography, etc.
Conventional gray-scale ultrasound and doppler ultrasound have low image resolution, and they have limited operation guidance functions [2, 3] aiming at intracranial lesion with deeper location and smaller diameter, especially some malignant tumors with aggressive growth characteristics. Ultrasound contrast enhances the echo comparison of blood flow and tissue through injecting ultrasound contrast agent (UCA) into the body. The blood perfusion difference between pathological tissue and normal tissue is utilized for prominently increasing the contrast of ultrasound images [4] . Tumor resection was performed smoothly for all patients in this experiment under the guidance of ultrasound contrast. The examination and implementation process of intraoperative ultrasound contrast is smooth without adverse reaction of contrast agent application. There were no serious complications after operation. It can be concluded that intraoperative ultrasound contrast is safe and feasible during application in intracranial tumor operative treatment.
It is discovered through study that the ultrasonic display rate of intracranial tumor is up to 100% because of the real-time imaging function of ultrasonoscopy [5] . However, it is more difficult for ultrasound to distinguish the lesions less than 1cm in the case of insufficient experience. The discrimination ability of ultrasound is poor during judgment of malignant tumor boundary, especially Research, volume 78 when the tumor has been partially resected, it is difficult to accurately judge the tumor boundary [6, 7] . However, the display of internal vascular structure and the relationship with adjacent blood vessels by ultrasound contrast is prominently better than routine ultrasound examination. Ultrasound contrast agent can be applied for accurately displaying the tumor location, tumor internal blood vessel and is relationship with adjacent blood vessel in real time, which is better than that before injection of contrast agent [8] . Ultrasound contrast agent belongs to blood pool imaging agent, which is only distributed in the blood vessels and does not diffuse to other parts outside the blood vessel [9] . Therefore, The infusion sequence of contrast agent, the distribution characteristics of signals, the enhancement intensity of the lesion and other imaging characteristics can be comprehended by analyzing the relevant parameters provided by time-intensity curve (TIC) of tumor enhancement [10] . These parameters reflect the metabolic characteristics of intracranial tumor for contrast agent, which partly reflect the biological characteristics of tumors.
Advances in Computer Science
In the experiment, normal brain tissue always shows low enhancement, the contrast enhancement intensity of tumor tissues was significantly higher than that of surrounding brain tissue. Ultrasonography is a simple, fast and cheap real-time imaging technology. Relevant studies have shown that intraoperative ultrasonography plays certain role in detection of residual tumor. It can provide an accurate and visualized tumor edge area during the operation, thereby helping neurosurgeons to find potential residual tumor. Woydt, etc. implemented tissue biopsy in the residual cavity aiming at 45 cases of supratentorial glioma resection.
In the experiment, The residual tumors were judged according to the enhancement characteristics of tissues around the residual cavity during ultrasound contrast examination, the specificity was 100%, and false positive rate was 0. However, routine ultrasound examination residual tumor judgement sensitivity was 41.7%, and false negative rate was 58.3%. While the ultrasound contrast judgment sensitivity was 83.3%, and the false negative rate was 16.7%. The above results suggested that ultrasound contrast has higher specificity and sensitivity in the aspect of judging whether there is residual tumor or not compared with routine ultrasound examination.
